Planning Directions Inc Merck & Co., Inc. Transaction History

Planning Directions Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$113.24 - $131.95 $31,707 - $36,946	-280 Reduced 13.07%	1,863 $245,000
Q4 2023 Jan 31, 2024	SELL	$100.18 - $109.02 $16,429 - $17,879	-164 Reduced 7.11%	2,143 $233,000
Q3 2023 Oct 27, 2023	BUY	$102.95 - $114.33 $1,132 - $1,257	11 Added 0.48%	2,307 $237,000
Q2 2023 Jul 19, 2023	BUY	$108.61 - $118.38 $17,377 - $18,940	160 Added 7.49%	2,296 $265,000
Q1 2023 May 11, 2023	BUY	$102.94 - $114.86 $219,879 - $245,340	2,136 New	2,136 $227,000
Q2 2020 Jul 21, 2020	SELL	$70.42 - $80.13 $352,100 - $400,650	-5,000 Closed	0 $0
Q1 2020 May 05, 2020	BUY	$63.36 - $87.82 $316,800 - $439,099	5,000 New	5,000 $385,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Planning Directions Inc, based on Form 13F filings with the SEC.

Stay updated on Planning Directions Inc with notifications on news.